Literature DB >> 1410160

Euphoriant effects of nicotine in smokers.

C S Pomerleau1, O F Pomerleau.   

Abstract

Two studies were conducted to replicate and extend previous demonstrations of smoking-induced, dose-related reports of euphoria, and to confirm this relationship using measures of plasma nicotine. In experiment 1, overnight-deprived subjects, in three different sessions, smoked ultralow-, high-nicotine, and usual-brand cigarettes. In experiment 2, ultralow-, medium-, and high-nicotine cigarettes were used, and plasma nicotine was measured. In both studies, subjects were asked to depress a button during euphoric sensations. Number of sensations for the ultralow-nicotine cigarette was significantly lower than for the high-nicotine cigarette in the first study, and than for both the medium- and high-nicotine conditions in the second; a significant linear trend was observed for number of sensations as a function of plasma nicotine level in the second study. For the high-nicotine cigarette, 19 of 22 subjects experienced at least one sensation (mean around three), starting around 2.5 min after lighting up. Together, these studies support the existence of a dose-response relationship for nicotine-induced euphoric sensations; suggest that they are more pronounced following overnight abstinence than following minimal deprivation, and in more dependent smokers; and characterize in detail the temporal features of these sensations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1410160     DOI: 10.1007/bf02247422

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  Human studies of the behavioral pharmacological determinants of nicotine dependence.

Authors:  J E Henningfield; S R Goldberg; R I Herning; D R Jasinski; S E Lukas; K Miyasato; R Nemeth-Coslett; W B Pickworth; J E Rose; A Sampson
Journal:  NIDA Res Monogr       Date:  1986

Review 2.  Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction.

Authors:  N L Benowitz
Journal:  N Engl J Med       Date:  1988-11-17       Impact factor: 91.245

3.  Progress report from the NIDA Addiction Research Center, Baltimore, Maryland.

Authors:  D R Jasinski; J J Boren; J E Henningfield; R E Johnson; W R Lange; S E Lukas
Journal:  NIDA Res Monogr       Date:  1984-03

4.  Tolerance development to the arousal effects of nicotine.

Authors:  J E Hubbard; R S Gohd
Journal:  Pharmacol Biochem Behav       Date:  1975 May-Jun       Impact factor: 3.533

Review 5.  Pharmacologic basis and treatment of cigarette smoking.

Authors:  J E Henningfield
Journal:  J Clin Psychiatry       Date:  1984-12       Impact factor: 4.384

6.  Measurement issues in cigarette smoking research: basic behavioral and physiological effects and patterns of nicotine self-administration.

Authors:  J E Henningfield
Journal:  NIDA Res Monogr       Date:  1983

7.  Reinforcing and other behavioral effects of nicotine.

Authors:  J Dougherty; D Miller; G Todd; H B Kostenbauder
Journal:  Neurosci Biobehav Rev       Date:  1981       Impact factor: 8.989

8.  Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment.

Authors:  K O Fagerström
Journal:  Addict Behav       Date:  1978       Impact factor: 3.913

9.  A high-performance liquid-chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma.

Authors:  M Hariharan; T VanNoord; J F Greden
Journal:  Clin Chem       Date:  1988-04       Impact factor: 8.327

10.  Mecamylamine reduces some EEG effects of nicotine chewing gum in humans.

Authors:  W B Pickworth; R I Herning; J E Henningfield
Journal:  Pharmacol Biochem Behav       Date:  1988-05       Impact factor: 3.533

View more
  37 in total

1.  Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation.

Authors:  Gary E Swan; Karen Suchanek Hudmon; Lisa M Jack; Kymberli Hemberger; Dorit Carmelli; Taline V Khroyan; Huijun Z Ring; Hyman Hops; Judy A Andrews; Elizabeth Tildesley; Dale McBride; Neal Benowitz; Chris Webster; Kirk C Wilhelmsen; Heidi S Feiler; Barbara Koenig; Lorraine Caron; Judy Illes; Li S-C Cheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-10       Impact factor: 4.254

2.  Euphoriant effects of nicotine in smokers: fact or artifact?

Authors:  Reuven Dar; Rachel Kaplan; Lior Shaham; Hanan Frenk
Journal:  Psychopharmacology (Berl)       Date:  2007-01-19       Impact factor: 4.530

3.  The effect of long term nicotine exposure on nicotine addiction and fetal growth.

Authors:  Soycan Mızrak; Volkan Turan; Mustafa Coşan Terek; Gülinnaz Ercan
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-12-01

4.  Acute tolerance to nicotine in smokers: lack of dissipation within 2 hours.

Authors:  K A Perkins; J E Grobe; S L Mitchell; J Goettler; A Caggiula; R L Stiller; A Scierka
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

5.  Smoking in schizophrenia: diagnostic specificity, symptom correlates, and illness severity.

Authors:  Roman Kotov; Lin T Guey; Evelyn J Bromet; Joseph E Schwartz
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

Review 6.  Hormones, nicotine, and cocaine: clinical studies.

Authors:  Nancy K Mello
Journal:  Horm Behav       Date:  2009-10-14       Impact factor: 3.587

Review 7.  Duality of Antidepressants and Neuroprotectants.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2015-11-27       Impact factor: 3.911

8.  Depressed mood and the effect of two universal first grade preventive interventions on survival to the first tobacco cigarette smoked among urban youth.

Authors:  Yan Wang; Dorothy C Browne; Hanno Petras; Elizabeth A Stuart; Fernando A Wagner; Sharon F Lambert; Sheppard G Kellam; Nicholas S Ialongo
Journal:  Drug Alcohol Depend       Date:  2008-12-06       Impact factor: 4.492

9.  Empirical support for a multi-dimensional model of sensations experienced by youth during their initial smoking episodes.

Authors:  Chris G Richardson; Chizimuzo T C Okoli; Pamela A Ratner; Joy L Johnson
Journal:  Addiction       Date:  2010-08-16       Impact factor: 6.526

10.  CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats.

Authors:  Olivier George; Sandy Ghozland; Marc R Azar; Pietro Cottone; Eric P Zorrilla; Loren H Parsons; Laura E O'Dell; Heather N Richardson; George F Koob
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.